Evidence map›Paper›PMID 35558930›Full record

ArticleRSC advances2018

Morphology-dependent pH-responsive release of hydrophilic payloads using biodegradable nanocarriers.

Sumit Kumar Pramanik, Senne Seneca, Martijn Peters, Lien D'Olieslaeger, Gunter Reekmans, Dirk Vanderzande, Peter Adriaensens, Anitha Ethirajan

Abstract read
In one paragraph

Article in RSC advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sumit Kumar PramanikInstitute for Materials Research (IMO), Hasselt University Wetenschapspark 1 and Agoralaan D, 3590 Diepenbeek Belgium anitha.ethirajan@uhasselt.be.ORCID https://orcid.org/0000-0002-0294-8829
Senne SenecaInstitute for Materials Research (IMO), Hasselt University Wetenschapspark 1 and Agoralaan D, 3590 Diepenbeek Belgium anitha.ethirajan@uhasselt.be.ORCID https://orcid.org/0000-0002-9939-9917
Martijn PetersInstitute for Materials Research (IMO), Hasselt University Wetenschapspark 1 and Agoralaan D, 3590 Diepenbeek Belgium anitha.ethirajan@uhasselt.be.
Lien D'OlieslaegerInstitute for Materials Research (IMO), Hasselt University Wetenschapspark 1 and Agoralaan D, 3590 Diepenbeek Belgium anitha.ethirajan@uhasselt.be.
Gunter ReekmansInstitute for Materials Research (IMO), Hasselt University Wetenschapspark 1 and Agoralaan D, 3590 Diepenbeek Belgium anitha.ethirajan@uhasselt.be.
Dirk VanderzandeInstitute for Materials Research (IMO), Hasselt University Wetenschapspark 1 and Agoralaan D, 3590 Diepenbeek Belgium anitha.ethirajan@uhasselt.be.ORCID https://orcid.org/0000-0002-9110-124X
Peter AdriaensensInstitute for Materials Research (IMO), Hasselt University Wetenschapspark 1 and Agoralaan D, 3590 Diepenbeek Belgium anitha.ethirajan@uhasselt.be.ORCID https://orcid.org/0000-0003-4183-0150
Anitha EthirajanInstitute for Materials Research (IMO), Hasselt University Wetenschapspark 1 and Agoralaan D, 3590 Diepenbeek Belgium anitha.ethirajan@uhasselt.be.ORCID https://orcid.org/0000-0002-2264-2536

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of functional nanocarriers with stimuli-responsive properties has advanced tremendously to serve biomedical applications such as drug delivery and regenerative medicine. However, the development of biodegradable nanocarriers that can be loaded with hydrophilic compounds and ensure its controlled release in response to changes in the surrounding environment still remains very challenging. Herein, we achieved such demands

Identifiers

PMID35558930
PMCPMC9088891

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.